
Am J Psychiatry 1979; 136:1184-1187
Copyright © 1979 by American Psychiatric Association
The comparative efficacy of buspirone and diazepam in the treatment of anxiety
HL Goldberg and RJ Finnerty
In this double-blind study, 56 adult psychoneurotic outpatients with a
primary diagnosis of anxiety neurosis were randomly assigned to receive
buspirone (N = 18), diazepam (N = 20), or placebo (N = 18) over a four-
week period. A battery of tests administered weekly indicated that
buspirone, a new agent not chemically related to any currently marketed
drugs, was as effective an antianxiety agent as diazepam and produced no
more and perhaps fewer side effects. Buspirone showed excellent
antidepressant effects as well. If further studies confirm the authors'
findings and determine that buspirone does not result in tolerance and
addiction, it would be more advantageous than the benzodiazepines in the
treatment of anxiety.
This article has been cited by other articles:

|
 |

|
 |
 
S. R. Chamberlain, U. Muller, J. B. Deakin, P. R. Corlett, J. Dowson, R. N. Cardinal, M. R. F. Aitken, T. W. Robbins, and B. J. Sahakian
Lack of deleterious effects of buspirone on cognition in healthy male volunteers
J Psychopharmacol,
March 1, 2007;
21(2):
210 - 215.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Raghavan, D. Zhang, M. Zhu, J. Zeng, and L. Christopher
CYP2D6 CATALYZES 5-HYDROXYLATION OF 1-(2-PYRIMIDINYL)-PIPERAZINE, AN ACTIVE METABOLITE OF SEVERAL PSYCHOACTIVE DRUGS, IN HUMAN LIVER MICROSOMES
Drug Metab. Dispos.,
February 1, 2005;
33(2):
203 - 208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Hoge, J. E. Oppenheimer, and N. M. Simon
Generalized Anxiety Disorder
Focus,
July 1, 2004;
2(3):
346 - 359.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Savic, P. Lindstrom, B. Gulyas, C. Halldin, B. Andree, and L. Farde
Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy
Neurology,
April 27, 2004;
62(8):
1343 - 1351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Renyi, J. L. Evenden, C. J. Fowler, E. Jerning, D. Kelder, D. Lake-Bakaar, L.-G. Larsson, N. Mohell, M. Sallemark, and S. B. Ross
The Pharmacological Profile of (R)-3,4-Dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a Selective 5-Hydroxytryptamine1A Receptor Agonist
J. Pharmacol. Exp. Ther.,
December 1, 2001;
299(3):
883 - 893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Vanecek, W. D. Essman, D. P. Taylor, and J. H. Woods
Discriminative Stimulus Characteristics of BMY 14802 in the Pigeon
J. Pharmacol. Exp. Ther.,
January 1, 1998;
284(1):
1 - 9.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
X.-o. Zhu and N. McNaughton
Similar effects of buspirone and chlordiazepoxide on a fixed interval schedule with long-term, low-dose administration
J Psychopharmacol,
January 1, 1995;
9(4):
326 - 330.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J.F.W. Deakin
A review of clinical efficacy of 5-HT 1A agonists in anxiety and depression
J Psychopharmacol,
January 1, 1993;
7(3):
283 - 289.
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rex, C.A. Marsden, and H. Fink
5-HT 1A receptors and changes in extracellular 5-HT in the guinea-pig prefrontal cortex: involvement in aversive behaviour
J Psychopharmacol,
January 1, 1993;
7(4):
338 - 345.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Panickar and N. McNaughton
Effects of buspirone on fixed interval responding in rats
J Psychopharmacol,
January 1, 1991;
5(4):
410 - 417.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Przegalinski, E. Tatarczynska, and E. Chojnacka-Wojcik
Anticonflict effect of ipsapirone, buspirone and gepirone is not mediated by their common metabolite 1-(2-pyrimidinyl)piperazine
J Psychopharmacol,
January 1, 1989;
3(3):
180 - 185.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C.T. Dourish, G.A. Kennett, and G. Curzon
The 5-HT1A agonists 8-OH-DPAT, buspirone and ipsapirone attenuate stress-induced anorexia in rats
J Psychopharmacol,
January 1, 1987;
1(1):
23 - 30.
[Abstract]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 1979
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|